1. Scrip
  2. >>Advanced Therapies
  3. >>Cell Therapies

Gene Therapy Investment At All Time High, Commercialization Challenges Noted

 
• By Jo Shorthouse

Investor appetite for cell and gene therapy companies has skyrocketed during the past year. However, storm clouds may gather as manufacturing and reimbursement challenges remain.

Tablet
• Source: Shutterstock

2018 saw a huge uptick in investment in gene therapy companies, but the path to efficient manufacture and commercial success for these products is still far from clear, new research from the Alliance for Regenerative Medicine suggests. 

2019 has so far continued the trend, kicking off with some big investments in gene therapy companies. Biogen Inc.’s $877m Nightstar Therapeutics PLC buy, which gives it access to the gene therapy developer’s expertise in retinal diseases, is the latest deal in big pharma’s quest to establish strongholds in this emerging area by investing heavily in companies and products that have disease-modifying potential

More from Cell Therapies

Which Firms Are Most Exposed To Prasad’s Possible Accelerated Approvals Clampdown?

 
• By Andrew McConaghie

Vaccine and accelerated approvals are expected to face greater scrutiny under new CBER leader Vinay Prasad, but he has promised “no light switch change” to policy, giving some reassurance to companies whose share prices have been battered.

Atara Does An About Face As FDA Lifts Ebvallo Hold

 
• By Alaric DeArment

The biotech said it will have a type A meeting with the agency to resubmit for the cell therapy’s approval in EBV+ PTLD.

Zelluna Believes Its TCR Tech Can Unlock Natural Killer Cell Potential

 
• By Andrew McConaghie

While CAR-NKs have pivoted towards autoimmune disease, the Norwegian biotech believes its unique platform can deliver in oncology

Gilead Pipeline Progress Offsets Oncology Sales Slowdown

 
• By Alaric DeArment

Sales of the company’s approved cancer therapies were weaker or down, but Trodelvy is likely to see a label expansion and cell therapies are making progress.

More from Advanced Therapies